4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001412071-26-000004
Options or other derivatives
- President and CEO acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Singh Shawn President and CEO | 2026-04-07 | Grant or award · Incentive Stock Option (right to buy) | +3,732 | 3,732 | D | ||
| Singh Shawn President and CEO | 2026-04-07 | Grant or award · Non-Qualified Stock Option (right to buy) | +71,268 | 71,268 | D | ||
Loading xslF345X06/edgardoc.xml…